Aayush Food and Herbs Ltd

Aayush Wellness Limited has expanded its nutraceutical portfolio with the launch of "Himalayan Shilajit Drops", entering the Shilajit-based wellness supplement category. The global Shilajit market is projected to reach USD 436.72 Million by 2034, growing at an 8.67% CAGR. This launch leverages the company's Singapore presence to tap into growing global demand and explore expansion opportunities across Southeast Asia and international markets. The product is positioned for daily energy, stamina, and vitality support, featuring a fulvic-acid-rich, mineral-dense formulation. This move aligns with India's growing nutraceutical industry, estimated at USD 30.37 billion and projected to grow at a CAGR of 13.6% between 2025 and 2030.

Aayush Wellness Limited announced its unaudited financial results for Q2 and H1 FY27, ending September 30, 2026. Consolidated total income for H1 FY27 grew 10.61% year-on-year to ₹7,061.82 Lakhs (₹6,384.84 Lakhs in H1 FY26). Consolidated Profit After Tax (PAT) increased by 5.86% to ₹250.10 Lakhs (₹236.26 Lakhs in H1 FY26). For Q2 FY27, consolidated total income was ₹3,685.67 Lakhs, a 9.17% sequential increase, with PAT at ₹108.48 Lakhs. Standalone total income for Q2 FY27 was ₹2,639.31 Lakhs, up 6.77% sequentially, and standalone PBT rose 12.57% to ₹135.01 Lakhs. The company also launched Aayush Calcium Vitamin Tablets, expanding its product portfolio in bone and joint health, following earlier launches of Lung Care Tablets and Dia Shield Tablets.

Aayush Wellness Limited announced its unaudited financial results for Q2 and H1 FY27. For H1 FY27, consolidated total income grew 10.61% YoY to ₹7,061.82 Lakhs (₹70.62 Crore), with consolidated PAT increasing 5.86% YoY to ₹250.10 Lakhs (₹2.50 Crore). In Q2 FY27, consolidated total income saw a 9.17% sequential growth to ₹3,685.67 Lakhs (₹36.86 Crore), and consolidated PAT was ₹108.48 Lakhs (₹1.08 Crore). Standalone Q2 FY27 income increased 6.77% sequentially to ₹2,639.31 Lakhs (₹26.39 Crore), with PBT rising 12.57% to ₹135.01 Lakhs (₹1.35 Crore). The company also appointed NKM & Associates as Secretarial Auditor for FY 2026-27 and highlighted new product launches in the bone and joint health segment.

Aayush Wellness Limited announced its un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated total income of ₹7,061.82 Lakhs for H1 FY27, a 10.61% year-on-year increase from ₹6,384.84 Lakhs in H1 FY26. Consolidated Profit After Tax (PAT) for H1 FY27 reached ₹250.10 Lakhs, up 5.86% year-on-year from ₹236.26 Lakhs in H1 FY26. For Q2 FY27, consolidated total income grew 9.17% sequentially to ₹3,685.67 Lakhs, with PAT at ₹108.48 Lakhs. On a standalone basis, Q2 FY27 total income was ₹2,639.31 Lakhs, a 6.77% sequential increase, and PBT rose 12.57% to ₹135.01 Lakhs. The company also appointed M/s. NKM & Associates as Secretarial Auditor for FY 2026-27.

Aayush Wellness Ltd has announced that its Board of Directors will convene on Tuesday, November 3, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, along with the limited review report. The trading window for company securities will reopen 48 hours after the declaration of these financial results.

Aayush Wellness Limited has expanded its nutraceutical portfolio with the launch of "Aayush Calcium Vitamin Tablets". This new product targets the significant calcium and vitamin deficiencies prevalent in India, aiming to support bone and joint health. The company is entering the rapidly growing USD 178 billion dietary supplements market, driven by increasing consumer focus on proactive wellness. The formulation includes Calcium Citrate, Vitamin D2, Magnesium, Zinc, and Folic Acid, designed for enhanced absorption and overall musculoskeletal vitality. This move aligns with Aayush Wellness's strategy to address critical nutritional gaps and capitalize on the expanding preventive healthcare sector in India.

Aayush Wellness Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's code of conduct for preventing insider trading. The window will be shut for promoters, directors, key management personnel, designated persons, and their immediate relatives starting October 1, 2026. It will reopen 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. The date of the board meeting to approve these results will be communicated separately.

Aayush Wellness Ltd has announced the cut-off date for e-voting for its 42nd Annual General Meeting (AGM) will be Tuesday, September 22, 2026. The AGM is scheduled for Tuesday, September 29, 2026, at 2:00 PM IST, to be conducted via Video Conferencing (VC) and Other Audio Visual Means (OAVM). The remote e-voting period will commence on Saturday, September 26, 2026, at 9:00 AM IST and conclude on Monday, September 28, 2026, at 5:00 PM IST. Central Depository Services (India) Limited (CDSL) has been appointed to facilitate the remote e-voting and e-voting during the AGM.

Aayush Wellness Ltd announced the resignation of Mr. Naveenakumar Kunjaru from his position as Managing Director, effective September 09, 2026. The resignation is attributed to personal and family commitments. Mr. Kunjaru also holds directorships in Empower India Limited, where he chairs the Audit, Nomination and Remuneration, and Stakeholders Relationship Committees. He has confirmed no other material reasons for his resignation.

Aayush Wellness Ltd has submitted its 42nd Annual Report for the Financial Year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report details the company's corporate overview, including its vision of building an integrated preventive healthcare ecosystem across herbal alternatives, nutraceuticals, and diagnostics. It also contains the notice for the 42nd Annual General Meeting, statutory reports, standalone and consolidated financial statements, and other relevant corporate information. The Annual Report is available on the company's website.